Short answer: A white label GLP-1 program lets your brand offer medical weight loss under your own name while a platform partner supplies the intake, licensed provider review, pharmacy fulfillment, subscriptions and refills behind it. Licensed providers decide who is eligible, pharmacies ship the medication, and you own the brand, the marketing and the patient experience.
A white label GLP-1 program is how many founders, med spas, gyms and clinicians add medical weight loss without building a clinic, a software stack and a pharmacy network from scratch. You bring the audience and the brand. A white-label telehealth platform brings the clinical and operational engine.
If you want the full clinical and regulatory playbook for the category, start with our guide on how to launch a GLP-1 digital clinic. This guide is different. It focuses on the white-label model itself: what you are actually getting, what stays your responsibility, and how to pick the right partner.
What is a white label GLP-1 program?
In a white-label model, the patient sees your logo, your website and your voice from the first ad to the refill reminder. Behind the scenes, a partner platform runs the workflow that turns a website visitor into a patient under the care of a licensed provider.
That split matters. You are not practicing medicine, and you are not running a pharmacy. You are running a brand and a business that connects patients to licensed providers and licensed pharmacies through a compliant workflow. Who can own what, and how the business and clinical sides are structured, depends on your state. Corporate practice of medicine rules vary widely, so review your structure with a healthcare attorney before you launch.
Who a GLP-1 white label model fits
- Founders and operators who want to build a weight management brand without clinical ownership.
- Med spas and aesthetic clinics that want to extend care to patients beyond their front door. See how to add telehealth to your med spa or gym.
- Gyms and wellness brands with an engaged audience that already asks about medical weight loss.
- Clinicians who want the software, pharmacy routing and billing handled so they can focus on care.
What does a white-label GLP-1 program include?
A complete program covers every step of the patient journey. Here is what to expect, and who typically owns each piece.
| Component | What it covers | Who typically owns it |
|---|---|---|
| Branded intake | Health history questionnaire in your brand, built so a provider can see every screening factor | Platform builds it, you brand it, providers shape the clinical questions |
| Provider review | Evaluation of each patient by a licensed provider in the patient’s state | Licensed provider network |
| Labs | Lab orders and results routed into the patient chart when the provider calls for them | Provider orders, platform routes |
| Pharmacy fulfillment | Brand-name and compounded 503A pathways, shipping and tracking | Licensed pharmacies |
| Subscriptions and refills | Recurring billing, check-ins and provider-approved refills | Platform runs it, providers approve refills |
| Patient portal | Secure messaging, visit history and a branded education library | Platform |
| Admin and reporting | Orders, patient stages and revenue reporting for your team | Platform provides, you operate |
| Brand and marketing | Website, ads, content, affiliates and referral links | You |
If a partner cannot show you each of these working together in a live demo, keep asking questions.
Brand-name vs compounded 503A pathways
This is the most important product decision in any white label weight loss program, and the one with the most regulatory weight.
Brand-name FDA-approved medications
Brand-name GLP-1 medications are FDA-approved products dispensed by licensed pharmacies. The product, labeling and dosing are defined by that approval, which is why many founders treat the brand-name pathway as the foundation of the program.
Compounded medications from a licensed 503A pharmacy
Compounded medications are prepared by a licensed 503A pharmacy for an individual patient based on a prescription. They are not FDA-approved, and FDA does not review them for safety, effectiveness or quality before they are marketed. Our guide on what a 503A pharmacy is explains how that pathway works.
The rules here move. FDA has declared the national shortages of semaglutide and tirzepatide injection products resolved, and federal law restricts compounding that is essentially a copy of a commercially available FDA-approved drug. The FDA drug shortage list and compounding policies can change at any time. Verify the current status of every product with a healthcare attorney and your pharmacy partner before it goes on your site, and again whenever FDA updates its guidance.
Either way, a licensed provider decides whether any treatment is appropriate for a specific patient. A pathway is an option the provider can consider, never a product the patient is promised.
Provider screening, eligibility and labs
In a well-run program, the intake informs and the provider decides. Your branded questionnaire should collect health history, current medications, prior conditions and anything FDA labeling calls out, so the licensed provider has what they need. Screening can flag a case for closer review, but it never approves anyone on its own.
Some patients will not be candidates. The provider may ask follow-up questions, require labs, request a live visit or decline to treat. Your program should make each of those outcomes smooth and respectful, and your marketing should never imply that every applicant will receive a prescription.
Labs are part of the workflow when the provider calls for them. Look for a partner that lets providers order labs from a catalog and routes results straight into the patient chart. For the operational details, read how to add lab testing to telehealth.
Subscriptions, refills and cold chain shipping
A GLP-1 white label program is an ongoing relationship, not a one-time sale. The follow-up workflow deserves as much attention as the first intake.
- Subscriptions: recurring billing that matches the care plan and makes pausing or cancelling clear.
- Check-ins: scheduled follow-ups where patients report side effects and questions to the provider.
- Refills: each refill approved by a licensed provider, never automatic without review.
- Messaging: a secure portal so patients can reach the care team between check-ins.
Many GLP-1 products are temperature sensitive. Ask each pharmacy partner how it packages and ships temperature-controlled orders, how it handles weather delays and damaged shipments, and how shipping status flows back into the patient record.
Marketing and compliance rules for a white label GLP-1 program
Marketing rules for GLP-1 ads
Weight loss marketing draws scrutiny from FDA, the FTC, ad platforms and payment processors. These are the guardrails we build every program around:
- No before and after photos. They imply typical results that no one can promise an individual patient.
- No guaranteed results. Never promise pounds, timelines or outcomes. Talk about the evaluation: “See if a GLP-1 medication may be right for you.”
- No guaranteed prescriptions. A licensed provider decides.
- Never call compounded medications FDA-approved, generic or the same as a brand-name drug.
- Be clear about who does what. Your brand connects patients to licensed providers and licensed pharmacies. It does not compound or prescribe.
- Follow each platform’s healthcare ad policy, which often requires certification before you can advertise prescription drugs.
Build these rules into your review process, so every ad, landing page and email is checked before it goes live, not after a platform flags it.
HIPAA, state rules and LegitScript
Three compliance layers sit under every program.
- HIPAA. Your platform handles protected health information, so it should run on HIPAA-ready infrastructure and sign a business associate agreement.
- State rules. Provider licensing follows the patient’s location, and ownership rules follow your state. A healthcare attorney should review both.
- LegitScript. Major ad platforms and card networks recognize LegitScript Healthcare Certification for businesses that market prescription drugs. The application reviews your site, your providers and your pharmacies, so accurate copy and clear partner disclosures matter. Our guide on how to get LegitScript certification for telehealth walks through it.
How to choose a white label GLP-1 partner
The partner you choose becomes the engine of your brand, so test it before you sign. Ask every vendor the same questions and get the answers in writing.
- Does my brand appear everywhere patients see it, with no vendor branding?
- Which brand-name and compounded 503A pathways are available, and how does the pharmacy explain its legal basis for anything compounded?
- How is the provider network licensed, and which states can it cover?
- Can providers order labs, and do results land in the chart?
- How do subscriptions, check-ins and refills work, and who approves each refill?
- How are temperature-controlled shipments handled?
- Will you sign a BAA, and what does the platform provide for my LegitScript application?
- How is pricing structured, and what happens to my data and patients if I leave?
For the full vendor checklist, read how to choose a white-label telehealth platform.
How to launch a white-label weight loss program: step by step
- Get legal guidance. Settle entity structure, corporate practice of medicine questions and your formulary with a healthcare attorney.
- Choose your partner. Run the questions above and walk through a real patient journey in a demo.
- Decide your pathways. Start with brand-name options, and add any compounded option only after counsel and the pharmacy confirm it fits current rules.
- Confirm provider coverage. Map the states you plan to serve against the provider network.
- Build your brand and intake. Branded site, intake and patient education library, with provider input on clinical questions.
- Set up merchant processing and LegitScript early. Both take time.
- Connect tracking and referrals. Meta and Google tracking, plus affiliate and referral links, set up in a HIPAA-conscious way.
- Review every claim. Check the site, ads and emails against the marketing rules above.
- Run test orders, then launch. Test intake to delivery to refill before real patients arrive.
How WellieMD supports your GLP-1 program
WellieMD is a white-label telehealth platform for digital clinics. For a white label GLP-1 program, it provides branded intake, licensed provider review through a provider network, pharmacy fulfillment through brand-name and compounded 503A pathways, a patient portal with messaging, follow-ups and refills, subscriptions, an admin dashboard with reporting, a lab catalog, a branded patient education library, affiliate and referral links, and Meta and Google tracking setup, all on HIPAA-ready infrastructure with 50-state coverage. Every clinical decision stays with licensed providers. See the full view on the white-label telehealth platform page.
If you also want a team to build the brand around it, our sister company GrowPro is a separate launch service that handles branding, website, LegitScript application support, merchant setup and marketing. WellieMD is the platform. GrowPro is the launch team. We build it with you.
Next step
A white label GLP-1 program works when the pieces fit: licensed providers making every clinical call, clear brand-name and compounded pathways, honest marketing and a partner you can trust with your brand. If you are ready to map yours out, book a WellieMD demo and bring your questions. Want to see the platform first? Watch the walkthroughs in our video library.
This guide is general information, not legal or medical advice. Prescription products require evaluation by a licensed provider. Compounded medications are not FDA-approved.
Sources
- U.S. Food and Drug Administration: FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize
- U.S. Food and Drug Administration: FDA to telehealth companies, what to know when promoting compounded drugs
- U.S. Food and Drug Administration: Human drug compounding laws
- LegitScript: Healthcare Merchant Certification FAQ